Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation: Mechanisms of tumor genesis

Iranian Journal of Kidney Diseases

Volumn 3, Issue 3, 2009, Pages 121-126

  Ahmadpoor, Pedram ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human herpesvirus 8; Kaposi sarcoma; Kidney transplantation

Indexed keywords

CYCLINE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; STAT3 PROTEIN;

CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME INACTIVATION; FEVER; GRAFT SURVIVAL; HEPATOSPLENOMEGALY; HUMAN; HUMAN HERPESVIRUS 8; IATROGENIC DISEASE; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; INCIDENCE; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; LYMPHOID HYPERPLASIA; OPEN READING FRAME; PANCYTOPENIA; PREVALENCE; REVIEW; SEROPREVALENCE; VIRUS TRANSMISSION; DISEASE TRANSMISSION; HERPES VIRUS INFECTION; STATISTICS; VIROLOGY;

HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; PREVALENCE; SARCOMA, KAPOSI;

EID: 70349903404     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005;16:1758-74.
2. Allen UD. Human herpesvirus type 8 infections among solid organ transplant recipients. Pediatr Transplant. 2002;6:187-92.
3. Frances C, Mouquet C, Calvez V. Human herpesvirus 8 and renal transplantation. N Engl J Med. 1999;340:1045.
4. Alzahrani AJ, El-Harith el HA, Milzer J, et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant. 2005;20:2532-6.
5. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev. 2003;67:175-212.
6. Kalt I, Masa SR, Sarid R. Linking the Kaposi's sarcomaassociated herpesvirus (KSHV/HHV-8) to human malignancies. Methods Mol Biol. 2009;471:387-407.
7. Viejo-Borbolla A, Schulz TF. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Rev. 2003;5:222-9.
8. Regamey N, Tamm M, Wernli M, et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med. 1998;339:1358-63.
9. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph. 1872;4:265-73.
10. Mendez JC, Paya CV. Kaposi's Sarcoma and Transplantation. Herpes. 2000;7:18-23.
11. Wong EL, Damania B. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus K15 gene. J Virol. 2006;80:1385-92.
12. Makhdoomi K, Ahmadpoor P, Ghafari A, Rostami R, Ahmadi F, Lessan Pezeshki M. Prevalence of malignancy after renal transplantation. Nephrol Dial Transplant. 2003;18: M756 [abstract].
13. Einollahi B, Lessan-Pezeshki M, Nourbala MH, et al. Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients. Int Urol Nephrol. 2009;41:679-85.
14. Andreoni M, Goletti D, Pezzotti P, et al. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect. 2001;43:195-9.
15. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-9.
16. Buonaguro FM, Tornesello ML, Beth-Giraldo E, et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer. 1996;65:25-8.
17. Mancuso R, Biffi R, Valli M, et al. HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J Med Virol. 2008;80:2153-60.
18. Ahmadpoor P, Ilkhanizadeh B, Sharifzadeh P, et al. Seroprevalence of human herpes virus-8 in renal transplant recipients: a single center study from Iran. Transplant Proc. 2007;39:1000-2.
19. Wimmer CD, Rentsch M, Crispin A, et al. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 2007;71:1271-8.
20. Horenstein MG, Moontasri NJ, Cesarman E. The pathobiology of Kaposi's sarcoma: advances since the onset of the AIDS epidemic. J Cutan Pathol. 2008;35 Suppl 2:40-4.
21. Pertel PE. Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J Virol. 2002;76:4390-400.
22. Krishnan HH, Sharma-Walia N, Streblow DN, Naranatt PP, Chandran B. Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells. J Virol. 2006;80:1167-80.
23. Punjabi AS, Carroll PA, Chen L, Lagunoff M. Persistent activation of STAT3 by latent Kaposi's sarcomaassociated herpesvirus infection of endothelial cells. J Virol. 2007;81:2449-58.
24. Nicholas J. Human herpesvirus-8-encoded signalling ligands and receptors. J Biomed Sci. 2003;10:475-89.
25. Van Dross R, Shan Y, Asad S, et al. Constitutively active K-cyclin /cdk6 kinase in Kaposi's sarcoma-associated herpes virus infected cells. J Natl Cancer Inst. 2005;97:656-66.
26. Kennedy MM, Biddolph S, Lucas SB, et al. Cyclin D1 expression and HHV8 in Kaposi sarcoma. J Clin Pathol. 1999;52:569-73.
27. Si H, Robertson ES. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J Virol. 2006;80:697-709.
28. Shin YC, Nakamura H, Liang X, et al. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol. 2006;80:2257-66.
29. Grisotto MG, Garin A, Martin AP, et al. The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest. 2006;116:1264-73.
30. Montaner S, Sodhi A, Molinolo A, et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell. 2003;3:23-36.
31. Montaner S. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle. 2007;6:438-43.
32. Jensen KK, Manfra DJ, Grisotto MG, et al. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol. 2005;174:3686-94.
33. Sodhi A, Chaisuparat R, Hu J, et al. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G proteincoupled receptor. Cancer Cell. 2006;10:133-43.
34. Choi YB, Nicholas J. Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol. 2008;82:6501-13.
35. Sodhi A, Montaner S, Gutkind JS. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? FASEB J. 2004;18:422-7.
36. Lebbe C, Euvrard S, Barrou B, et al. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant. 2006;6:2164-8.
37. Stoeltzing O, Meric-Bernstam F, Ellis LM. Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected. Cancer Cell. 2006;10:89-91.
38. Stallone G, Infante B, Grandaliano G, Schena FP, Gesualdo L. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int. 2008;21:825-32.
39. Campistol JM, Albanell J, Arns W, et al. Use of proliferation signal inhibitors in the management of posttransplant malignancies--clinical guidance. Nephrol Dial Transplant. 2007;22 Suppl 1:i36-41.
40. Montaner S, Sodhi A, Ramsdell AK, et al. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res. 2006;66:168-74.
41. El-Agroudy AE, El-Baz MA, Ismail AM, Ali-El-Dein B, El-Dein AB, Ghoneim MA. Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients. Am J Transplant. 2003;3:1595-9.
42. Brown EE, Fallin D, Ruczinski I, et al. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev. 2006;15:926-34.
43. Foster CB, Lehrnbecher T, Samuels S, et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood. 2000;96:2562-7.
44. Pati S, Foulke JS, Jr., Barabitskaya O, et al. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol. 2003;77:5759-73.
45. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996;2:918-24.
46. Quinlivan EB, Zhang C, Stewart PW, Komoltri C, Davis MG, Wehbie RS. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis. 2002;185:1736-44.
47. Engels EA, Biggar RJ, Marshall VA, et al. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS. 2003;17:1847-51.
48. Campbell TB, Borok M, Gwanzura L, et al. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. Aids. 2000;14:2109-16.